Nano-formulations for transdermal drug delivery: A review

被引：145
作者：
Zhou, Xingli [1 ]
Hao, Ying [1 ]
Yuan, Liping [1 ]
Pradhan, Sushmita [1 ]
Shrestha, Krista [1 ]
Pradhan, Ojaswi [1 ]
Liu, Hongjie [1 ]
Li, Wei [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Dermatovenereol, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China
来源：
CHINESE CHEMICAL LETTERS | 2018年 / 29卷 / 12期
关键词：
Nano-formulation; Transdermal drug delivery system; Classification; Mechanism; Application; NANOSTRUCTURED LIPID CARRIERS; TEMOPORFIN-LOADED INVASOMES; TOPICAL CO-DELIVERY; SKIN IN-VITRO; STRATUM-CORNEUM; PHOTODYNAMIC THERAPY; DEFORMABLE LIPOSOMES; EXPERIMENTAL-DESIGN; VESICULAR CARRIERS; SILDENAFIL CITRATE;
D O I：
10.1016/j.cclet.2018.10.037
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Transdermal drug delivery refers to a means of delivering drugs through the surface of the skin for local or systemic treatment. The drug functions after absorption through the skin into the systemic circulation via capillary action at a certain rate. Use of traditional physical and chemical enhancers to improve the transdermal permeation rate by increasing drug solubility, diffusion coefficient, and reservoir effect is not feasible owing to the toxic side effects of the overuse of chemical penetration enhancers. Nano formulations generally vary in size and range from 10 nm to 100 nm. The smaller particle size leads to increased drug permeability, stability, retention, and targeting, making nano-formulations suitable for transdermal drug delivery. The different applications of nano-formulations (vesicles or nanoparticles and nanoemulsions) have been widely studied. Here, the classification, characteristics, transdermal mechanism, and application of the most popular nano-formulations in transdermal drug delivery system are reviewed. (C) 2018 Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码：1713 / 1724
页数：12
相关论文
共 191 条
[1]   Niosomes and discomes for ocular delivery of naltrexone hydrochloride: Morphological, rheological, spreading properties and photo-protective effects [J].
Abdelkader, Hamdy ;
Wu, Zimei ;
Al-Kassas, Raida ;
Alany, Raid G. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 433 (1-2) :142-148
[2]  
Adib ZM, 2016, ADV PHARM BULL, V6, P31, DOI [10.15171/apb.2016.06, 10.15171/apb.2016.006]
[3]   Preparation and evaluation of antifungal efficacy of griseofulvin loaded deformable membrane vesicles in optimized guinea pig model of Microsporum canis-Dermatophytosis [J].
Aggarwal, Nidhi ;
Goindi, Shishu .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 437 (1-2) :277-287
[4]   Pharmacodynamic study of eprosartan mesylate-loaded transfersomes Carbopol® gel under Dermaroller® on rats with methyl prednisolone acetate-induced hypertension [J].
Ahad, Abdul ;
Al-Saleh, Abdulmohsen A. ;
Al-Mohizea, Abdullah M. ;
Al-Jenoobi, Fahad I. ;
Raish, Mohammad ;
Yassin, Alaa Eldeen B. ;
Alam, Mohd Aftab .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 89 :177-184
[5]   Technology overview and drug delivery application of proniosome [J].
Ahmad, Mohammad Zaki ;
Mohammed, Abdul Aleem ;
Ibrahim, Mahmoud Mokhtar .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2017, 22 (03) :302-311
[6]   Nanostructured lipid carriers of pioglitazone for transdermal application: from experimental design to bioactivity detail [J].
Alam, Sohrab ;
Aslam, Mohammed ;
Khan, Anam ;
Imam, Syed Sarim ;
Aqil, Mohammed ;
Sultana, Yasmin ;
Ali, Asgar .
DRUG DELIVERY, 2016, 23 (02) :601-609
[7]   Nanostructured Lipid Carrier for Topical Application of N-Acetyl Glucosamine [J].
Aliasgharlou, Lavin ;
Ghanbarzadeh, Saeed ;
Azimi, Hamideh ;
Zarrintan, Mohammad Hossein ;
Hamishehkar, Hamed .
ADVANCED PHARMACEUTICAL BULLETIN, 2016, 6 (04) :581-587
[8]   Early pathogenesis of atherosclerosis: The childhood obesity [J].
Amati, Luigi ;
Chiloiro, Marisa ;
Jirillo, Emilio ;
Covelli, Vito .
CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (36) :3696-3700
[9]  
Anton N, 2008, J CONTROL RELEASE, V128, P185, DOI 10.1016/j.jconrel.2008.02.007
[10]   The Role of Filaggrin in the Skin Barrier and Disease Development [J].
Armengot-Carbo, M. ;
Hernandez-Martin, A. ;
Torrelo, A. .
ACTAS DERMO-SIFILIOGRAFICAS, 2015, 106 (02) :86-95
12345678910